Works matching DE "POTENTIA Pharmaceuticals Inc."
Results: 2
Experimental AMD drug shows promise in phase 1 study.
- Published in:
- Ocular Surgery News, 2008, v. 26, n. 6, p. 50
- By:
- Publication type:
- Article
Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 922, doi. 10.1038/nrd3063
- Publication type:
- Article